Elekta’s Project Atlantic: A New Blue Ocean For Radiation Therapy
Executive Summary
Elekta AB is counting on rapid uptake of its new first-generation MRI-guided radiation therapy technology after its CE-marking and FDA clearance, anticipated in 2017. The so-called Project Atlantic combines high-field real-time MR imaging with state-of-the-art linear technology that, in the words of Elekta president and CEO Niklas Savander, will take the standard of care to the next level.
You may also be interested in...
Start-Ups Reduce Radiation Exposure
The use of cancer radiation therapy and interventional fluoroscopy is expanding rapidly, and start-ups are pioneering innovative technologies to capitalize on the industry-wide movement to reduce radiation exposure and improve outcomes. Profiles of ControlRad Systems, Nanovi, and SoniTrack Systems.
Elekta: Growing from the Head Down
Elekta established its reputation with the Leksell Gamma Knife for neurosurgery. Now, after a turnaround, it is expanding into a comprehensive cancer care company.
UK MHRA In The Spotlight As Cumberlege Review Puts Medtech Safety At The Top Of Health Agenda
The findings of the Cumberlege Review into how safety issues for three medical product groups were handled will shape debate on the UK’s new devices legislation, now going through parliament. The MHRA’s devices regulatory activity also comes in for scrutiny.
Need a specific report? 1000+ reports available
Buy Reports